BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31744879)

  • 1. AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis.
    Buensuceso A; Ramos-Valdes Y; DiMattia GE; Shepherd TG
    Mol Cancer Res; 2020 Mar; 18(3):488-500. PubMed ID: 31744879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
    Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG
    J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LSR promotes epithelial ovarian cancer cell survival under energy stress through the LKB1-AMPK pathway.
    Takahashi Y; Serada S; Ohkawara T; Fujimoto M; Hiramatsu K; Ueda Y; Kimura T; Takemori H; Naka T
    Biochem Biophys Res Commun; 2021 Jan; 537():93-99. PubMed ID: 33388415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for NUAK1 in promoting ovarian cancer metastasis through regulation of fibronectin production in spheroids.
    Fritz JL; Collins O; Saxena P; Buensuceso A; Ramos Valdes Y; Francis KE; Brown KR; Larsen B; Colwill K; Gingras AC; Rottapel R; Shepherd TG
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.
    Buensuceso A; Fritz JL; Collins O; Valdés YR; Borrelli MJ; DiMattia GE; Shepherd TG
    Sci Rep; 2022 Feb; 12(1):3011. PubMed ID: 35194062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis.
    Frederick MI; Hovey OFJ; Kakadia JH; Shepherd TG; Li SSC; Heinemann IU
    Mol Cell Proteomics; 2023 Nov; 22(11):100660. PubMed ID: 37820923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
    Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation.
    McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK
    Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
    Xu JH; Wang Y; Xu D
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
    He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
    Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
    Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
    Peng J; Yang X; Li X; Gao H; Liu N; Guo X
    Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.
    Goodwin JM; Svensson RU; Lou HJ; Winslow MM; Turk BE; Shaw RJ
    Mol Cell; 2014 Aug; 55(3):436-50. PubMed ID: 25042806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
    Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
    Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.